GlassScriptPhysician profile
Jennifer Mcdonald
NPI 1376641886
$7,070.07
in general payments reported to CMS, 2019-2025
45 companies · $645 in 2025
The $645 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,431 · 2020: $490 · 2021: $927 · 2022: $836 · 2023: $1,018 · 2024: $722 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,385.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $2,034.17 | 2019-2021 | |
| Abbvie INC. | $1,058.03 | 2019-2024 | |
| Amgen INC. | $411.01 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $398.41 | 2021-2025 | |
| Sage Therapeutics, LLC | $312.82 | 2021-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $282.32 | 2020-2022 | |
| Evofem Biosciences, INC. | $259.16 | 2022-2025 | Phexxi, Solosec, Phexx |
| Astellas Pharma US INC | $257.67 | 2022-2025 | Veozah, Myrbetriq |
| Medtronic, INC. | $246.93 | 2022-2025 | Interstim, Truclear |
| Exeltis, USA INC. | $199.98 | 2019-2025 | Slynd |
| Agile Therapeutics, INC. | $195.10 | 2021-2024 | Twirla |
| Organon LLC | $134.42 | 2022-2025 | Nexplanon, Jada System |
| Sumitomo Pharma America, INC. | $108.22 | 2023-2025 | Myfembree |
| Myriad Women'S Health, INC. | $102.49 | 2023 | Myrisk |
| Lupin INC. | $77.35 | 2020-2021 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $73.77 | 2024-2025 | Myosure Tissue Removal Device, Aptima, Thinprep 2000 Processor |
| Exact Sciences Corporation | $64.68 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $63.02 | 2019-2025 | |
| Novo Nordisk INC | $60.58 | 2020-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $58.53 | 2023-2025 | |
| Mylan Pharmaceuticals INC. | $52.16 | 2021-2022 | |
| Myovant Sciences INC. | $49.83 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $46.73 | 2019-2021 | |
| Lilly USA, LLC | $43.65 | 2022 | |
| Aesculap, INC. | $43.37 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $42.37 | 2022-2023 | Contrave |
| Cumberland Pharmaceuticals, INC. | $38.71 | 2023-2024 | Caldolor |
| Coopersurgical, INC. | $31.42 | 2025 | Paragard T 380a, Endosee |
| Glaxosmithkline, LLC. | $30.55 | 2020-2021 | |
| Virtus Pharmaceuticals LLC | $30.14 | 2021 | |
| Daiichi Sankyo INC. | $23.70 | 2022 | |
| Baxter Healthcare | $23.23 | 2023 | Perclot |
| Tersera Therapeutics LLC | $22.24 | 2019 | |
| Qiagen, LLC | $20.43 | 2019 | |
| Ethicon US, LLC | $20.22 | 2022 | |
| Vertical Pharmaceuticals, LLC | $18.25 | 2019 | |
| Lsi Solutions INC | $18.23 | 2024 | Fornisee |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.65 | 2020 | |
| Amag Pharmaceuticals, INC. | $16.06 | 2019 | |
| Dexcom, INC. | $15.73 | 2023 | Dexcom G6 Transmitter |
| Millicent US INC | $15.65 | 2025 | Femlyv |
| Ibsa Pharma INC. | $14.50 | 2023 | Tirosint, Licart |
| Supernus Pharmaceuticals, INC. | $13.98 | 2025 | Qelbree |
| Duchesnay USA Incorporated | $12.04 | 2019 | |
| Radius Health, INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.